Study of SA+X in the Treatment of Newly Diagnosed AML

Clinical trial NCT07548710 · RECRUITING

Trial details

NCT number: NCT07548710
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2026-05-01
Primary completion: 2027-05-31
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.